Effect of the glucagon‐like peptide‐1 analogue liraglutide versus placebo treatment on circulating proglucagon‐derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial-Reference-Cited by-同舟云学术

Effect of the glucagon‐like peptide‐1 analogue liraglutide versus placebo treatment on circulating proglucagon‐derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial

Published:2020-11-19 Issue:2 Volume:23 Page:489-498
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Kim Sun H.¹²^ORCID,Abbasi Fahim²³,Nachmanoff Clara¹,Stefanakis Konstantinos⁴,Kumar Ajay⁵,Kalra Bhanu⁵,Savjani Gopal⁵,Mantzoros Christos S.⁴^ORCID

Affiliation:

1. Division of Endocrinology, Gerontology and Metabolism, Department of Medicine Stanford University School of Medicine Stanford California USA

2. Stanford Diabetes Research Center Stanford University School of Medicine Stanford California USA

3. Division of Cardiovascular Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA

4. Department of Medicine, Boston VA Healthcare System and Department of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

5. Ansh Labs Webster Texas USA

Funder

American Diabetes Association

National Institutes of Health

Stanford Diabetes Research Center

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14242

Reference27 articles.